WHO ICTRP trial
Study to evaluate the long-term safety, tolerability and efficacy of bimekizumab…
EUCTR2016-001892-57-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2016-001892-57-HU |
|---|---|
| Public title | Study to evaluate the long-term safety, tolerability and efficacy of bimekizumab in patients with chronic plaque psoriasis. |
| Scientific title | A Multicenter, 48-Week, Double-Blind, Placebo-Controlled, Parallel-Group Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects with Moderate to Severe Chronic Plaque Psoriasis. |
| Primary sponsor | UCB Biopharma SPRL |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Czech Republic;Hungary;Canada;Poland;Japan |
| Conditions | Chronic plaque psoriasis MedDRA version: 19.1 Level: LLT Classification code 10071117 Term: Plaque psoriasis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Immune System Diseases [C20] |
| Interventions | Product Name: Bimekizumab Product Code: UCB4940 Pharmaceutical Form: Solution for injection INN or Proposed INN: Bimekizumab CAS Number: 1418205-77-2 Other descriptive name: UCB4940 Concentration unit: mg/ml milligram(s)/millilitre… |
| Registration date | Sep 21, 2016 |
| Target size | 240 |
| Secondary IDs | PS0011 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: